Search Results

Repurposing the Tyrosine Kinase Inhibitors Targeting FGFR and VEGFR Pathways for Cancer Therapy: A Comprehensive Review.

• Authors : Boichuk, Sergei^1,2,3 (AUTHOR) ; Gessel, Tatyana^1,2 (AUTHOR)

• Source: Cancers. Oct2025, Vol. 17 Issue 20, p3354. 39p.

Record details

Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.

• Authors : Mavridis, Evangelos¹ (AUTHOR); Hadjipavlou-Litina, Dimitra¹ (AUTHOR)

• Source: International Journal of Molecular Sciences. Oct2025, Vol. 26 Issue 20, p10207. 43p.

Record details

Tyrosine-kinase inhibitors for lung or breast cancer and drug–drug interactions: a clinical guide.

• Authors : Santamaria, Fiorenza¹ (AUTHOR) ; Roberto, Michela² (AUTHOR); Maltese, Giulia^2,3 (AUTHOR)

• Source: Oncology Reviews. 2025, p1-10. 10p.

Record details

Small-Molecule Tyrosine Kinase Inhibitors Modulate Glucose Handling in C2C12 Cell Line In Vitro: A Mechanistic Study.

• Authors : Mugiya, Takudzwa¹ (AUTHOR); Zvandasara, Samarah^1,2 (AUTHOR); Mothibe, Mmamosheledi¹ (AUTHOR)

• Source: Pharmaceuticals (14248247). Oct2025, Vol. 18 Issue 10, p1445. 20p.

Record details

Adverse Reactions of First‐Line Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma Treatment: A Descriptive Analysis From WHO‐VigiAccess.

• Authors : Sui, Wei fan¹ (AUTHOR); Duan, Yu xin¹ (AUTHOR); Cai, Ze feng¹ (AUTHOR)

• Source: International Journal of Hepatology. 9/12/2025, Vol. 2025, p1-5. 5p.

Record details

Electric Field-Driven Modulation of Nanomechanical Interactions Between Tyrosine Kinase Inhibitors and Human Serum Albumin: Insights from AFM-Based Force Spectroscopy.

• Authors : Fu, Yuna¹ (AUTHOR); Wang, Jianhua¹ (AUTHOR) ; Gu, Di¹ (AUTHOR)

• Source: Molecules. Sep2025, Vol. 30 Issue 17, p3558. 18p.

Record details

Design and Synthesis of Dual Tyrosine Kinase Inhibitors Against Pancreatic Cancer

• Authors : Torres Urtizberea, Endika; University/Department: Universitat Ramon Llull. IQS; ...

Subjects: Drug Design; Pancreatic Cancer; Tyrosine Kinase Inhibitors

• Source: TDX (Tesis Doctorals en Xarxa)

Record details

Risk prediction of QTc prolongation occurrence in cancer patients treated with commonly used oral tyrosine kinase inhibitors: machine learning modeling or conventional statistical analysis better?

• Authors : Lin, Hsiang-Wen^1,2,3 (AUTHOR); Lin, Tien-Chao² (AUTHOR); Hsu, Chien-Ning^4,5 (AUTHOR)

• Source: BMC Medical Informatics & Decision Making. 8/15/2025, Vol. 25 Issue 1, p1-14. 14p.

Record details

Design, Docking Analysis, and Structure–Activity Relationship of Ferrocene-Modified Tyrosine Kinase Inhibitors: Insights into BCR-ABL Interactions.

• Authors : Philipova, Irena¹ (AUTHOR); Atanasova, Mariyana² (AUTHOR); Mihaylova, Rositsa^1,2 (AUTHOR)

• Source: Molecules. Aug2025, Vol. 30 Issue 15, p3101. 22p.

Record details

Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis.

• Authors : Meng, Lingbin¹; Psutka, Sarah P.²; Gheeya, Jinesh¹

• Source: Journal of Cancer. 2025, Vol. 16 Issue 14, p4047-4054. 8p.

Record details